Literature DB >> 15367401

Towards understanding the peripheral T-cell lymphomas.

J O Armitage, J M Vose, D D Weisenburger.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15367401     DOI: 10.1093/annonc/mdh409

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  15 in total

Review 1.  Novel therapies in peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2008-10       Impact factor: 3.952

Review 2.  Novel therapies in peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

3.  Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature.

Authors:  Mariantina Fragou; Dimitrios Karakitsos; Alexandros Kalogeromitros; George Samonis; Andreas Karabinis
Journal:  J Med Case Rep       Date:  2009-10-27

4.  Cutaneous manifestations of unspecified peripheral T-cell lymphoma may be indicative of disease activity and predict response to therapy.

Authors:  Michael K Schowalter; Oleg E Akilov; Sara K Story; Larisa J Geskin
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

5.  Peripheral T Cell Lymphoma Presenting with Hypereosinophilia.

Authors:  V Mehta; S Hameed; C Balachandran; A Roy
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules.

Authors:  Anjani Kumar; Sukh Mahendra Singh
Journal:  Mol Cell Biochem       Date:  2012-08-15       Impact factor: 3.396

Review 7.  Chimeric antigen receptor T-cell therapies for lymphoma.

Authors:  Jennifer N Brudno; James N Kochenderfer
Journal:  Nat Rev Clin Oncol       Date:  2017-08-31       Impact factor: 66.675

Review 8.  Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China.

Authors:  Xianping Lu; Zhiqiang Ning; Zhibin Li; Haixiang Cao; Xinhao Wang
Journal:  Intractable Rare Dis Res       Date:  2016-08

9.  Progressive tumor growth-associated altered tumor microenvironment: implications in a tumor stage-dependent modulation in survival of a murine T cell lymphoma.

Authors:  Vivek Singh; Sukh Mahendra Singh
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

10.  Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial.

Authors:  Hyeyeol Bae; Junichi Tsuchiya; Takehito Okamoto; Ikuko Ito; Yusuke Sonehara; Fumiko Nagahama; Kazunori Kubota; Ukihide Tateishi
Journal:  Jpn J Radiol       Date:  2018-09-24       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.